1. Del Llano, J.: Discussion point: should governments buy drug patents? Eur. J. Health Econ. 8(2), 173–177 (2007)
2. Espin, J., Schlander, M., Godman, B., Anderson, P., Mestre-Ferrandiz, J., Borget, I., et al.: Projecting pharmaceutical expenditure in EU5 to 2021: adjusting for the impact of discounts and rebates. Appl. Health Econ. Health Policy 16, 803–817 (2018). https://doi.org/10.1007/s40258-018-0419-1
3. Sarnak, D.O., Squires, D., Kuzmak, G., Bishop, S.: Paying for prescription drugs around the world: why is the US an outlier? Issue Brief (Commonw. Fund) 2017, 1–14 (2017)
4. Sarewitz, D.: Saving science. New Atlantis 49(Spring/Summer), 4–40 (2016)
5. European Comission: communication from the commission to the european parliament, the council, the european economic and social committee and the committee of the regions. https://ec.europa.eu/health/sites/health/files/human-use/docs/pharmastrategy_com2020-761_en.pdf